Triple-negative breast cancer (TNBC) is a highly heterogeneous disease defined by the absence of estrogen receptor (ER) and progesterone receptor (PR) expression. and human epidermal growth factor receptor 2 (HER2) overexpression that lacks targeted treatments. leading to dismal clinical outcomes. Thus. https://www.aitsglobal.com/product-category/options_hidden_product/